Johnson & Johnson (J&J) and its subsidiary DePuy Orthopedics were slapped with a massive $502 million in damages verdict from a jury in March that found both companies negligent in failing to warn patients of the risks of its metal hip implants. The companies are facing thousands of additional lawsuits and the next set of trials are scheduled to begin in early September.
However, J&J and DePuy are asking to delay the September trials so they can have more time to file an appeal of the March verdict in the 5th Circuit Court of Appeals. Lawyers for the companies are worried the next set of trials will likely have the same ruling and the company could face over $1 billion in damages before their appeal is ever heard.
J&J isn’t just sweating bullets over its defective hip implants either. The company is waiting for the Pennsylvania Supreme Court to decide if punitive damages will be awarded in the latest Risperdal lawsuit. If the Supreme Court affirms the punitive damages, it will set a precedent for thousands of other Risperdal lawsuits, which could make the difference between paying out thousands of dollars to Risperdal victims to paying millions.
The states of Washington and California recently filed lawsuits against J&J over its pelvic mesh, and J&J is facing two more talcum powder lawsuits before the year is out. The company is also facing lawsuits over the blood thinner Xarelto, the diabetes medication Invokana, and its power morcellator device.
While it is unclear whether or not J&J’s delay will be granted, one thing is for sure: J&J is fighting a multitude of multimillion lawsuits and none of them seem to be going well for them. The rest of 2016 and 2017 will surely be a rough year for Johnson & Johnson.